5.43
price up icon0.56%   0.03
pre-market  Vorhandelsmarkt:  5.38   -0.05   -0.92%
loading
Schlusskurs vom Vortag:
$5.40
Offen:
$5.4
24-Stunden-Volumen:
738.43K
Relative Volume:
0.62
Marktkapitalisierung:
$1.22B
Einnahmen:
$596.48M
Nettoeinkommen (Verlust:
$123.72M
KGV:
9.9015
EPS:
0.5484
Netto-Cashflow:
$106.59M
1W Leistung:
+0.37%
1M Leistung:
-0.18%
6M Leistung:
+37.12%
1J Leistung:
+43.27%
1-Tages-Spanne:
Value
$5.38
$5.44
1-Wochen-Bereich:
Value
$5.38
$5.49
52-Wochen-Spanne:
Value
$2.37
$5.72

Curevac N V Stock (CVAC) Company Profile

Name
Firmenname
Curevac N V
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
1,088
Name
Twitter
Name
Nächster Verdiensttermin
2025-04-10
Name
Neueste SEC-Einreichungen
Name
CVAC's Discussions on Twitter

Vergleichen Sie CVAC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CVAC
Curevac N V
5.43 1.22B 596.48M 123.72M 106.59M 0.5484
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Curevac N V Stock (CVAC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-13 Herabstufung Jefferies Buy → Hold
2024-04-25 Herabstufung Leerink Partners Outperform → Market Perform
2023-06-08 Eingeleitet SVB Securities Outperform
2023-01-19 Hochstufung UBS Neutral → Buy
2023-01-09 Hochstufung Jefferies Hold → Buy
2022-01-21 Herabstufung BofA Securities Neutral → Underperform
2022-01-18 Eingeleitet JMP Securities Mkt Outperform
2021-10-22 Eingeleitet Deutsche Bank Hold
2021-06-17 Herabstufung BofA Securities Buy → Neutral
2021-04-26 Fortgesetzt Credit Suisse Underperform
2021-04-26 Eingeleitet Guggenheim Neutral
2020-12-10 Herabstufung Credit Suisse Neutral → Underperform
2020-09-08 Eingeleitet BofA Securities Buy
2020-09-08 Eingeleitet Credit Suisse Neutral
2020-09-08 Eingeleitet Jefferies Hold
Alle ansehen

Curevac N V Aktie (CVAC) Neueste Nachrichten

pulisher
01:28 AM

CureVac N.V.Finanzen.net - Finanzen.net

01:28 AM
pulisher
Jul 22, 2025

What analysts say about CureVac N.V. stockFree Consultation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

CureVac N.V. Stock Analysis and ForecastUnmatched profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives CureVac N.V. stock priceSky-high return potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Is CureVac N.V. a good long term investmentExceptional stock performance - Autocar Professional

Jul 20, 2025
pulisher
Jul 14, 2025

CureVac: Pipeline pruning’s nasty effect - MarketScreener

Jul 14, 2025
pulisher
Jul 09, 2025

CureVac N.V. (CVAC) Has Gained Over 16% In One Month. Here Is Why - Insider Monkey

Jul 09, 2025
pulisher
Jul 05, 2025

Tesla chief Elon Musk teams up with Covid-19 player CureVac to build ‘RNA microfactories’ - Endpoints News

Jul 05, 2025
pulisher
Jun 26, 2025

CureVac Announces Key Resolutions from Annual Shareholders Meeting - TipRanks

Jun 26, 2025
pulisher
Jun 26, 2025

CureVac (CVAC) Downgraded by UBS as Acquisition Looms | CVAC Stock News - GuruFocus

Jun 26, 2025
pulisher
Jun 26, 2025

CureVac stock downgraded to neutral by UBS after BioNTech acquisition - Investing.com UK

Jun 26, 2025
pulisher
Jun 24, 2025

CureVac Announces Key Appointments and Auditor Reappointment at Annual Meeting - TipRanks

Jun 24, 2025
pulisher
Jun 20, 2025

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech - Zacks Investment Research

Jun 20, 2025
pulisher
Jun 18, 2025

Private-Public Deal Momentum Grows, Yet Megamergers Stay Elusive - Investing.com

Jun 18, 2025
pulisher
Jun 17, 2025

BioNTech SE Announces Acquisition of CureVac N.V. - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Germany: BioNTech to acquire CureVac in all-stock transaction - Investors in Healthcare

Jun 17, 2025
pulisher
Jun 16, 2025

BioNTech to Acquire CureVac in Strategic Move - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

CureVac agrees to pay Biontech termination fee Of $43.8 mln under specified circumstances - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

5 Stocks To Ride The German Market RallyCureVac (NASDAQ:CVAC), BioNTech (NASDAQ:BNTX) - Benzinga

Jun 16, 2025
pulisher
Jun 15, 2025

BioNTech to Acquire CureVac in US$1.25 Billion All-Stock Transaction - Global Legal Chronicle

Jun 15, 2025
pulisher
Jun 15, 2025

There's No Escaping CureVac N.V.'s (NASDAQ:CVAC) Muted Revenues Despite A 50% Share Price Rise - simplywall.st

Jun 15, 2025
pulisher
Jun 14, 2025

CureVac’s SWOT analysis: mRNA pioneer’s stock faces pivotal year ahead By Investing.com - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of - Bluefield Daily Telegraph

Jun 13, 2025
pulisher
Jun 13, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders - TradingView

Jun 13, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech CureVac Acquisition Boosts Cancer Drug Pipeline - Industry Leaders Magazine

Jun 13, 2025
pulisher
Jun 13, 2025

CureVac (CVAC) Receives Downgrade and Price Target Reduction fro - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

Jefferies cuts CureVac stock rating to hold on BioNTech acquisition By Investing.com - Investing.com UK

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech: Oddo BHF raises target price - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech to buy CureVac in USD 1.25 billion all-stock deal - Medical Dialogues

Jun 13, 2025
pulisher
Jun 13, 2025

CureVac Stock: BioNTech's Billion-Dollar Takeover Bid - sharewise

Jun 13, 2025
pulisher
Jun 12, 2025

BioNTech (BNTX) to Acquire CureVac in $1.25 Billion All-Stock De - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac (CVAC) Downgraded by Jefferies Analyst After BioNTech Acquisition Agreement | CVAC Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech Announces Strategic Transaction to Acquire CureVac in P - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech Announces Strategic Acquisition of CureVac - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Biontech’s $1.25B Curevac buyout removes mRNA lawsuit uncertainty - BioWorld MedTech

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to Acquire CureVac in $1.25B Deal - USA Herald

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer (BNTX) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

5 Firms Guide $1.25B BioNTech, CureVac Oncology Deal - Law360

Jun 12, 2025
pulisher
Jun 12, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, SOAR, MTWO on Behalf of Shareholders - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to acquire CureVac in $1.25 billion all-stock deal By Investing.com - Investing.com South Africa

Jun 12, 2025

Finanzdaten der Curevac N V-Aktie (CVAC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):